A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.
PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...
Morning Overview on MSN
Scientists traced why H5N1 bird flu hits cows’ udders instead of their lungs
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
For nearly half a century, scientists have known that malaria parasites force their way into human red blood cells through a ring-shaped structure called the moving junction. What no one could work ...
Researchers have developed a way to program human cells to perform calculations and make autonomous decisions, similar to how ...
Daisy-chaining two of Dell's Nvidia GB10 DGX Spark systems didn't just pump up my home AI lab—it fundamentally changed how I ...
Advanced chip packaging, which boosts computing power for artificial intelligence, has made the United States more reliant on ...
Microsoft’s new Majorana 2 quantum chip offers 1,000 times more reliability. Learn how AI agents and lead superconductors ...
Researchers have developed a new LiDAR approach that makes it possible to image small objects with much greater precision and ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
From this basis emerged the clinical confidence that diagnostic truth lived somewhere at the far end of a resolution curve. Butterfly Network may be challenging that premise from the ground up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results